Polymorphisms within the human tumor necrosis factor-α promoter region in human immunodeficiency virus type 1-seropositive persons

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 188-190

  Brinkman, Brigitta M N ^b   Keet, Ireneus P M ^b   Miedema, Frank ^b   Verweij, Cor L ^b   Klein, Michel R ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENE;

EID: 0031032661     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.188     Document Type: Article

References (17)

1. Klein MR, Miedema F. Long term survivors of HIV-1 infection. Trends Microbiol 1995; 3:368-91.
2. Klein MR, Keet IPM, D'Amaro J, et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type-I infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994; 169:1244-9.
3. Just JJ. Genetic predisposition to HIV-1 infection and acquired immunodeficiency virus syndrome. Hum Immunol 1995; 44:156-69.
4. Keet IP, Klein MR, Just JJ, Kaslow RA. The role of host genetics in the natural history of HIV-1 infection: the needles in the haystack. AIDS 1996; 10(suppl A):59-67.
5. Jacob CO, Fronek Z, Lewis CD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
6. Wilson AG, De Vries N, Pociot F, Di Giovine FS, Van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor or promoter region is strongly associated with HLA-A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-60.
7. Brinkman BMN, Giphart MJ, Verhoef A, et al. Tumor necrosis factor α -308 gene variants in relation to major histocompatibility complex alleles and Felly's syndrome. Hum Immunol 1994; 41:259-66.
8. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-17.
9. Osbom L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin I stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86:233641.
10. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
11. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995; 211:833-9.
12. D'Alfonso SD, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFα promoter region. Immunogenetics 1994; 39: 150-4.
13. Centers for Disease Control. Revision of the CDC surveillance case definition of AIDS. MMWR 1987; 36:3-15.
14. Verduyn W, Doxiadis HN, Anholts J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993; 35:59-66.
15. McGuire W, Hill AVS, Allisopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-11.
16. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the TNFα -308 promoter polymorphism in TNFα gene regulation. J Inflamm 1996; 46:32-41.
17. Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996; 46;42-50.